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Original Article
Objectives: This retrospective cohort study aimed at calculating some parameters of changes in the findings of the subsequent 
screening mammography (SSM) in female Korean volunteers. 
Methods: The study included screenees aged 30 to 79 years who underwent SSM voluntarily after testing negative in the baseline 
screenings performed between January 2007 and December 2011. A change to a positive result was defined as category 4 or 5 by us-
ing the American College of Radiology Breast Imaging Reporting and Data System. The proportion of results that had changed to pos-
itive (CP, %) was calculated by dividing the number of cases with results that were positive in the SSM by the total number of study 
participants. The rate of results that had changed to positive (CR, cases per 100 000 screenee-months) was calculated by dividing the 
number of cases with results that were positive in the SSM by the total number of months of the follow-up period. 
Results: The overall CP and CR in all age groups (n=77 908) were 2.26% and 93.94 cases per 100 000 screenee-months, respectively. 
The median CP interval in the subjects who had positive SSM results was 30 to 36 months, while that in the age group of 30 to 39 
years was shorter. 
Conclusions: Different screening intervals should be considered among women aged between 30 and 59 years. In addition, a strategy 
for a screening program should be developed for the age group of 30 to 39 years, in particular.
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INTRODUCTION
The breast is the leading site of cancer incidence worldwide 
[1], and the second leading site in Korean women [2]. While the 
pISSN 1975-8375 eISSN 2233-4521 
global burden of breast cancer in women is substantial and in-
creasing [3], 26 countries in the International Cancer Screening 
Network have operated a screening program developed on the 
basis of epidemiological characteristics in their countries [4]. 
Most programs focus on women aged 50 to 69 years with an 
interval of 2 years between screenings [5,6]. The National Can-
cer Center in Korea recommends biennial screening with mam-
mography in women ≥40 years of age [7]. However, this rec-
ommendation was not made fully on the basis of epidemiolog-
ical evidence of breast cancer in Korean women, although Ko-
rean women had an age-incidence curve markedly different 
from that of Western women [8].
To adapt the nationwide recommendation of cancer screen-
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ing, any evidence related to the detection method, age groups 
covered, and recommended interval for modality should be ob-
tained [9]. In particular, the age and interval between tests could 
be determined by estimating the mean sojourn time (MST) of 
the targeted cancer [10-12]. 
The MST could be defined as the mean time from the screen-
ing of a detectable size to that of a clinically detectable size [13]. 
If the date of subsequent screening showing positive findings 
was considered to be the date of clinical diagnosis, the duration 
between the date of baseline screening with negative findings 
and that of subsequent screening mammography (SSM) with 
positive findings could be considered the individually underes-
timated sojourn time in breast cancer [12]. Thus, the aim of the 
study was to calculate the proportions, rates, and periods of 
changing findings in the SSM among voluntary screenees to 




The source population was the same as that in the study by 
Bae et al. [10] and Bae et al. [11]. In the screening programs pro-
vided by the Korea Medical Institute [14], full-field digital mam-
mography is the primary modality for the initial and follow-up 
screening of breast cancer. 
The selection criteria for constructing the baseline cohort 
from the source population were female Korean volunteers 
aged 30 to 79 years who underwent SSM after initial negative 
results during the first (baseline) screening between January 
2007 and December 2011. The age at the time of screening was 
determined by the date of the baseline screening mammogra-
phy starting in January 2007. Some SSMs conducted within 
less than 6 months of the previous test were treated the same 
as those in the previous test because the authors took into con-
sideration that the tests would be performed by administrative 
issues such as conducting a cancelled screening, etc. 
Definition of the Change to Mammographic 
Positivity
All screening mammograms were interpreted using the 
American College of Radiology Breast Imaging Reporting and 
Data System [15]. Among the five assessment categories, posi-
tive results were defined as category 4 (likely malignant) or 5 
(malignant). 
All screenees consented to undergoing screening mammog-
raphy and the use of personal data for research. The study pro-
tocol was approved by the institutional review board of Jeju 
National University Hospital (file no. 2013-09-005). 
Statistical Analysis
The subjects were classified into five age groups: 30 to 39, 
40 to 49, 50 to 59, 60 to 69, and 75 to 79 years. The proportion 
of results that had changed to positive (CP, %) was calculated 
by dividing the number of cases with results that were posi-
tive in the SSM by the total number of screenees with negative 
results in the baseline screening. The follow-up periods strati-
fied by age group were calculated as the number of months 
from the date of the first screening mammography to the date 
of a positive SSM result. If the last screening result was normal, 
the date of this test was considered to be the end of follow-up 
for that subject. From this follow-up information, the rate of 
change to a positive mammographic result (CR, cases per 100 
000 screenee-months) was calculated by dividing the number 
of cases with results that were positive in the SSM by the total 
number of months of the follow-up period. The 95% confi-
dence intervals (CIs) for CP and CR were calculated using the 
Poisson distribution. Lifetime method was used to estimate 
the cumulative CP at 6-month intervals. The log-rank test was 
conducted for testing the equality over age groups. A p-value 
of <0.05 was considered to be statistically significant in the 
two-sided tests. All statistical tests were performed using STA-
TA version 12 (StataCorp, College Station, TX, USA).
RESULTS
Among the eligible population (n=188 022), 77 908 (41.44%) 
screenees underwent SSM (Table 1). The overall CP in all age 
Table 1. Participating rates (%) of SSMs among the eligible 
population (n=188 022) who had negative results in the 
baseline mammography





30-79 188 022 (100.0) 77 908 (100.0) 41.14
30-39 31 493 (16.75) 11 925 (15.31) 37.87
40-49 82 831 (44.05) 38 130 (48.94) 46.03
50-59 46 444 (24.72) 19 505 (25.04) 42.00
60-69 19 659 (10.46) 6417 (8.24) 32.64
70-79 7595 (4.04) 1931 (2.48) 25.42
SSM, subsequent screening mammography.
1C (%)=B/A.
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groups was 2.66% among 77 908 subjects (Table 2). The young-
est age group showed the highest CP, and CP decreased with 
an increase in age. The 95% CIs of CPs among the age groups of 
30 to 69 years did not overlap. The overall CR in all age groups 
was 93.94 cases per 100 000 screenee-months (95% CI, 89.94 
to 98.08). The CRs among all age groups had the same trend as 
the CPs (Table 3). The 95% CIs of CRs among the age groups of 
30 to 59 years did not overlap.
Table 4 shows the cumulative CPs by age groups at intervals 
of 6 months. The median CP interval for the subjects with a posi-
tive SSM result was 30 to 36 months, while that for the group 
aged 30 to 39 years was shorter. In the log-rank test for equality 
over age groups, the p-value was <0.001. Figure 1 shows that 
the cumulative CPs in the age group of 30 to 39 years were the 
most different from those in the other age groups.
DISCUSSION
Although, to the best of our knowledge, there has not been a 
previous study evaluating the parameters of changing SSM re-
sults of Korean screenees, the overall CR implies that 1 case of 
12 772 screenees per year had a positive SSM result in the age 
group of 30 to 79 years. On the basis of cumulative CPs, one-half 
of the screenees with a positive SSM result had a changed result 
during 30 to 36 months, without an overlap with the 95% CIs for 
the age group of 30 to 59 years. However, these findings may be 
indirect evidence for determining the interval of SSM in healthy 
Korean women because these parameters did not suggest the 
MST directly, but estimated it indirectly [12].
Some statistical methods to estimate the MST by using Mon-








CP (%) [C]1 95% CI
30-79 2069 (100.0) 77 908 (100.0) 2.66 2.54, 2.77
30-39 447 (21.60)  11 925 (15.31) 3.75 3.41, 4.11
40-49 1072 (51.81)  38 130 (48.94) 2.81 2.64, 2.98
50-59 428 (20.69)  19 505 (25.04) 2.19 1.99, 2.41
60-69 102 (4.93)  6417 (8.24) 1.59 1.29, 1.93
70-79 20 (0.97)  1931 (2.48) 1.04 0.63, 1.60
CP, proportion of results that had changed to positive; SSM, subsequent 
screening mammography; CI, confidence interval.   
1C=A/B.
Table 3. Total follow-up and its CR (per 100 000 screenee-
months)
Age (y) Cases [A in Table 2]
Total follow-up
 (mo) [B] CR [C]
1 95% CI
30-79 2069 2 202 389.26 93.94 89.94, 98.08
30-39 447 289 841.25 154.23 140.25, 169.21
40-49 1072 1 111 688.54 96.43  90.74, 102.38
50-59 428 569 532.91 75.15 68.20, 82.62
60-69 102 178 705.61 57.08 46.54, 69.29
70-79 20 52 620.94 38.01 23.22, 58.70
CR, rate of results that changed to positive result; CI, confidence interval.
1C=A/B.
Table 4. Cumulative proportion (%) of results that changed to positive results, as obtained using the life table method
Interval (mo) 30-39 40-49 50-59 60-69 70-79 30-79
[6, 12) 0.0 0.0 0.0 0.0 0.0 0.0
[12, 18) 17.1 (16.4,17.7) 10.3 (10.0,10.6) 10.0 (9.6,10.4) 9.5 (8.8,10.2) 8.0 (6.8,9.3) 11.1 (10.9,11.3)
[18, 24) 35.3 (34.4,36.1) 21.8 (21.4,22.2) 21.1 (20.6,21.7) 21.1 (20.1,22.1) 20.0 (18.3,21.8) 23.6 (23.3,23.9)
[24, 30) 52.7 (51.8,53.6) 38.5 (38.0,39.0) 38.7 (38.0,39.4) 42.9 (41.7,44.1) 43.3 (41.1,45.5) 41.2 (40.8,41.5)
[30, 36) 70.6 (69.7,71.4) 56.3 (55.8,56.8) 56.8 (56.1,57.5) 63.1 (61.9,64.3) 66.8 (64.7,68.9) 59.4 (59.1,59.8)
[36, 42) 79.5 (78.8,80.3) 66.6 (66.1,67.0) 67.4 (66.7,68.0) 73.6 (72.6,74.7) 76.8 (74.9,78.7) 69.6 (69.2,69.9)
[42, 48) 88.2 (87.6,88.8) 77.9 (77.5,78.3) 77.2 (76.6,77.8) 81.4 (80.4,82.3) 84.1 (82.5,85.7) 79.7 (79.4,80.0)
[48, 54) 93.7 (93.3,94.2) 87.9 (87.6,88.2) 88.9 (88.4,89.3) 92.4 (91.8,93.1) 93.0 (91.9,94.2) 89.5 (89.3,89.7)
[54, 60) 99.5 (99.4,99.7) 99.3 (99.3,99.4) 99.5 (99.4,99.6) 99.5 (99.3,99.7) 99.6 (99.3,99.9) 99.4 (99.4,99.5)
Figure 1. Curves of the cumulative proportion of results that 
had changed to positive results in subsequent screening 
mammographies (%) by age groups.
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te Carlo-Markov models have been reported [16]. However, 
they require the knowledge of the nationwide mammographic 
sensitivity by age group among Korean women [13]. The direct 
estimation of MST could not be determined, because nation-
wide cancer-related information could not be obtained easily 
owing to legal barriers in Korea [10-12].
Nevertheless, the age group of 30 to 39 years showed higher 
CP, higher CR, and earlier changes in the cumulative CP than 
the other age groups. These findings are in agreement with the 
findings of a previous study that reported breast cancer with a 
shorter sojourn time (ST) and more aggressive progression 
among younger women [6]. These findings suggest that in Ko-
rean women, the strategy of screening for breast cancer for the 
age group of 30 to 39 years should be different from that used 
for the other age groups [8,17-19]. In other words, these find-
ings are the rationale for the suggestion of shorter screening 
intervals in the younger age group [20].
Several limitations should be considered for a valid interpreta-
tion of our results. The first is the assumption in calculating the 
individual ST. It is certain that the date of SSM with positive find-
ings was not the same as that of clinical diagnosis, because 
some cases with positive SSM findings would be diagnosed as 
breast cancer later. However, the date of SSM with positive find-
ings preceded that of the final diagnosis; thus, the estimated in-
dividual ST in this study was likely to be an underestimate of the 
actual ST. The second limitation is the self-selection bias. Be-
cause the study subjects were voluntary attendees of screening, 
they did not represent Korean women on the whole. Although 
these screenees may have been more interested in cancer pre-
vention, the findings obtained from them could still be used as 
evidence supporting the recommendation of a national cancer-
screening program for Korean women because they received 
results only after undergoing SSM. The third limitation is the in-
ability to evaluate SSM performance at other institute. On the 
basis of a retrospective cohort study design, the authors calcu-
lated the CR by using screenee-months. The last limitation is the 
degree of accuracy in reading the screening mammograms. But 
our study used readings from a single institution, the conclu-
sions can be expected to have been more reliable than they 
would have been from multiple institutions, and the level of va-
lidity of the readings at our institution would not be different 
from the nationwide value. 
In conclusion, different screening intervals should be consid-
ered for the age groups of 30 to 39, 40 to 49, and 50 to 59 years. 
In addition, a strategy for a screening program should be sug-
gested for the age group of 30 to 39 years, in particular. Because 
the incidence rate of breast cancer is increasing, the suggested 
screening guidelines for the early detection of breast cancer in 
Korean women should be adapted regularly on the basis of the 
related evidence obtained from Korean women [8,17-19,21]. 
Thus, an additional study for the direct estimation of MST in 
breast cancer using Monte Carlo-Markov models should be per-
formed after obtaining nationwide information on the sensitivity 
by age group to correctly interpret the results of this study [12].
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